Global Autoimmune Disorder Drug Delivery Device Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Autoimmune Disorder Drug Delivery Device Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Autoimmune Disorder Drug Delivery Device by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Autoimmune Disorder Drug Delivery Device by Country/Region, 2017, 2022 & 2028

2.2 Autoimmune Disorder Drug Delivery Device Segment by Type

2.2.1 Pen Injectors

2.2.2 Auto-Injectors

2.2.3 Prefilled Syringes

2.2.4 Vials

2.3 Autoimmune Disorder Drug Delivery Device Sales by Type

2.3.1 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2017-2022)

2.3.2 Global Autoimmune Disorder Drug Delivery Device Revenue and Market Share by Type (2017-2022)

2.3.3 Global Autoimmune Disorder Drug Delivery Device Sale Price by Type (2017-2022)

2.4 Autoimmune Disorder Drug Delivery Device Segment by Application

2.4.1 In-house Manufacturing

2.4.2 Outsourced Manufacturing

2.5 Autoimmune Disorder Drug Delivery Device Sales by Application

2.5.1 Global Autoimmune Disorder Drug Delivery Device Sale Market Share by Application (2017-2022)

2.5.2 Global Autoimmune Disorder Drug Delivery Device Revenue and Market Share by Application (2017-2022)

2.5.3 Global Autoimmune Disorder Drug Delivery Device Sale Price by Application (2017-2022)

3 Global Autoimmune Disorder Drug Delivery Device by Company

3.1 Global Autoimmune Disorder Drug Delivery Device Breakdown Data by Company

3.1.1 Global Autoimmune Disorder Drug Delivery Device Annual Sales by Company (2020-2022)

3.1.2 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Company (2020-2022)

3.2 Global Autoimmune Disorder Drug Delivery Device Annual Revenue by Company (2020-2022)

3.2.1 Global Autoimmune Disorder Drug Delivery Device Revenue by Company (2020-2022)

3.2.2 Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Company (2020-2022)

3.3 Global Autoimmune Disorder Drug Delivery Device Sale Price by Company

3.4 Key Manufacturers Autoimmune Disorder Drug Delivery Device Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Autoimmune Disorder Drug Delivery Device Product Location Distribution

3.4.2 Players Autoimmune Disorder Drug Delivery Device Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Autoimmune Disorder Drug Delivery Device by Geographic Region

4.1 World Historic Autoimmune Disorder Drug Delivery Device Market Size by Geographic Region (2017-2022)

4.1.1 Global Autoimmune Disorder Drug Delivery Device Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Autoimmune Disorder Drug Delivery Device Annual Revenue by Geographic Region

4.2 World Historic Autoimmune Disorder Drug Delivery Device Market Size by Country/Region (2017-2022)

4.2.1 Global Autoimmune Disorder Drug Delivery Device Annual Sales by Country/Region (2017-2022)

4.2.2 Global Autoimmune Disorder Drug Delivery Device Annual Revenue by Country/Region

4.3 Americas Autoimmune Disorder Drug Delivery Device Sales Growth

4.4 APAC Autoimmune Disorder Drug Delivery Device Sales Growth

4.5 Europe Autoimmune Disorder Drug Delivery Device Sales Growth

4.6 Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Growth

5 Americas

5.1 Americas Autoimmune Disorder Drug Delivery Device Sales by Country

5.1.1 Americas Autoimmune Disorder Drug Delivery Device Sales by Country (2017-2022)

5.1.2 Americas Autoimmune Disorder Drug Delivery Device Revenue by Country (2017-2022)

5.2 Americas Autoimmune Disorder Drug Delivery Device Sales by Type

5.3 Americas Autoimmune Disorder Drug Delivery Device Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Autoimmune Disorder Drug Delivery Device Sales by Region

6.1.1 APAC Autoimmune Disorder Drug Delivery Device Sales by Region (2017-2022)

6.1.2 APAC Autoimmune Disorder Drug Delivery Device Revenue by Region (2017-2022)

6.2 APAC Autoimmune Disorder Drug Delivery Device Sales by Type

6.3 APAC Autoimmune Disorder Drug Delivery Device Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Autoimmune Disorder Drug Delivery Device by Country

7.1.1 Europe Autoimmune Disorder Drug Delivery Device Sales by Country (2017-2022)

7.1.2 Europe Autoimmune Disorder Drug Delivery Device Revenue by Country (2017-2022)

7.2 Europe Autoimmune Disorder Drug Delivery Device Sales by Type

7.3 Europe Autoimmune Disorder Drug Delivery Device Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Autoimmune Disorder Drug Delivery Device by Country

8.1.1 Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Country (2017-2022)

8.1.2 Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue by Country (2017-2022)

8.2 Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Type

8.3 Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Autoimmune Disorder Drug Delivery Device

10.3 Manufacturing Process Analysis of Autoimmune Disorder Drug Delivery Device

10.4 Industry Chain Structure of Autoimmune Disorder Drug Delivery Device

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Autoimmune Disorder Drug Delivery Device Distributors

11.3 Autoimmune Disorder Drug Delivery Device Customer

12 World Forecast Review for Autoimmune Disorder Drug Delivery Device by Geographic Region

12.1 Global Autoimmune Disorder Drug Delivery Device Market Size Forecast by Region

12.1.1 Global Autoimmune Disorder Drug Delivery Device Forecast by Region (2023-2028)

12.1.2 Global Autoimmune Disorder Drug Delivery Device Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Autoimmune Disorder Drug Delivery Device Forecast by Type

12.7 Global Autoimmune Disorder Drug Delivery Device Forecast by Application

13 Key Players Analysis

13.1 AbbVie Inc.

13.1.1 AbbVie Inc. Company Information

13.1.2 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Product Offered

13.1.3 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AbbVie Inc. Main Business Overview

13.1.5 AbbVie Inc. Latest Developments

13.2 Amgen Inc.

13.2.1 Amgen Inc. Company Information

13.2.2 Amgen Inc. Autoimmune Disorder Drug Delivery Device Product Offered

13.2.3 Amgen Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Amgen Inc. Main Business Overview

13.2.5 Amgen Inc. Latest Developments

13.3 F. Hoffmann- La Roche Ltd.

13.3.1 F. Hoffmann- La Roche Ltd. Company Information

13.3.2 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Product Offered

13.3.3 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 F. Hoffmann- La Roche Ltd. Main Business Overview

13.3.5 F. Hoffmann- La Roche Ltd. Latest Developments

13.4 Novartis AG

13.4.1 Novartis AG Company Information

13.4.2 Novartis AG Autoimmune Disorder Drug Delivery Device Product Offered

13.4.3 Novartis AG Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Novartis AG Main Business Overview

13.4.5 Novartis AG Latest Developments

13.5 GlaxoSmithKline Plc

13.5.1 GlaxoSmithKline Plc Company Information

13.5.2 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Product Offered

13.5.3 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GlaxoSmithKline Plc Main Business Overview

13.5.5 GlaxoSmithKline Plc Latest Developments

13.6 Biogen Inc.

13.6.1 Biogen Inc. Company Information

13.6.2 Biogen Inc. Autoimmune Disorder Drug Delivery Device Product Offered

13.6.3 Biogen Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Biogen Inc. Main Business Overview

13.6.5 Biogen Inc. Latest Developments

13.7 Merck KGaA

13.7.1 Merck KGaA Company Information

13.7.2 Merck KGaA Autoimmune Disorder Drug Delivery Device Product Offered

13.7.3 Merck KGaA Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Merck KGaA Main Business Overview

13.7.5 Merck KGaA Latest Developments

13.8 Bayer AG

13.8.1 Bayer AG Company Information

13.8.2 Bayer AG Autoimmune Disorder Drug Delivery Device Product Offered

13.8.3 Bayer AG Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bayer AG Main Business Overview

13.8.5 Bayer AG Latest Developments

13.9 Johnson & Johnson Services Inc.

13.9.1 Johnson & Johnson Services Inc. Company Information

13.9.2 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Product Offered

13.9.3 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Johnson & Johnson Services Inc. Main Business Overview

13.9.5 Johnson & Johnson Services Inc. Latest Developments

13.10 Teva Pharmaceutical Industries Ltd.

13.10.1 Teva Pharmaceutical Industries Ltd. Company Information

13.10.2 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Product Offered

13.10.3 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Teva Pharmaceutical Industries Ltd. Main Business Overview

13.10.5 Teva Pharmaceutical Industries Ltd. Latest Developments

13.11 Eli Lily and Company

13.11.1 Eli Lily and Company Company Information

13.11.2 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Product Offered

13.11.3 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Eli Lily and Company Main Business Overview

13.11.5 Eli Lily and Company Latest Developments

13.12 Sanofi S.A.

13.12.1 Sanofi S.A. Company Information

13.12.2 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Product Offered

13.12.3 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Sanofi S.A. Main Business Overview

13.12.5 Sanofi S.A. Latest Developments

13.13 Takeda Pharmaceutical Company Limited

13.13.1 Takeda Pharmaceutical Company Limited Company Information

13.13.2 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Product Offered

13.13.3 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Takeda Pharmaceutical Company Limited Main Business Overview

13.13.5 Takeda Pharmaceutical Company Limited Latest Developments

14 Research Findings and Conclusion

Table 1. Autoimmune Disorder Drug Delivery Device Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Autoimmune Disorder Drug Delivery Device Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Pen Injectors

Table 4. Major Players of Auto-Injectors

Table 5. Major Players of Prefilled Syringes

Table 6. Major Players of Vials

Table 7. Global Autoimmune Disorder Drug Delivery Device Sales by Type (2017-2022) & (K Units)

Table 8. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2017-2022)

Table 9. Global Autoimmune Disorder Drug Delivery Device Revenue by Type (2017-2022) & ($ million)

Table 10. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Type (2017-2022)

Table 11. Global Autoimmune Disorder Drug Delivery Device Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Autoimmune Disorder Drug Delivery Device Sales by Application (2017-2022) & (K Units)

Table 13. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2017-2022)

Table 14. Global Autoimmune Disorder Drug Delivery Device Revenue by Application (2017-2022)

Table 15. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Application (2017-2022)

Table 16. Global Autoimmune Disorder Drug Delivery Device Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Autoimmune Disorder Drug Delivery Device Sales by Company (2020-2022) & (K Units)

Table 18. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Company (2020-2022)

Table 19. Global Autoimmune Disorder Drug Delivery Device Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Company (2020-2022)

Table 21. Global Autoimmune Disorder Drug Delivery Device Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Autoimmune Disorder Drug Delivery Device Producing Area Distribution and Sales Area

Table 23. Players Autoimmune Disorder Drug Delivery Device Products Offered

Table 24. Autoimmune Disorder Drug Delivery Device Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Autoimmune Disorder Drug Delivery Device Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Autoimmune Disorder Drug Delivery Device Sales Market Share Geographic Region (2017-2022)

Table 29. Global Autoimmune Disorder Drug Delivery Device Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Autoimmune Disorder Drug Delivery Device Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Country/Region (2017-2022)

Table 33. Global Autoimmune Disorder Drug Delivery Device Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Autoimmune Disorder Drug Delivery Device Sales by Country (2017-2022) & (K Units)

Table 36. Americas Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2017-2022)

Table 37. Americas Autoimmune Disorder Drug Delivery Device Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2017-2022)

Table 39. Americas Autoimmune Disorder Drug Delivery Device Sales by Type (2017-2022) & (K Units)

Table 40. Americas Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2017-2022)

Table 41. Americas Autoimmune Disorder Drug Delivery Device Sales by Application (2017-2022) & (K Units)

Table 42. Americas Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2017-2022)

Table 43. APAC Autoimmune Disorder Drug Delivery Device Sales by Region (2017-2022) & (K Units)

Table 44. APAC Autoimmune Disorder Drug Delivery Device Sales Market Share by Region (2017-2022)

Table 45. APAC Autoimmune Disorder Drug Delivery Device Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Autoimmune Disorder Drug Delivery Device Revenue Market Share by Region (2017-2022)

Table 47. APAC Autoimmune Disorder Drug Delivery Device Sales by Type (2017-2022) & (K Units)

Table 48. APAC Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2017-2022)

Table 49. APAC Autoimmune Disorder Drug Delivery Device Sales by Application (2017-2022) & (K Units)

Table 50. APAC Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2017-2022)

Table 51. Europe Autoimmune Disorder Drug Delivery Device Sales by Country (2017-2022) & (K Units)

Table 52. Europe Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2017-2022)

Table 53. Europe Autoimmune Disorder Drug Delivery Device Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2017-2022)

Table 55. Europe Autoimmune Disorder Drug Delivery Device Sales by Type (2017-2022) & (K Units)

Table 56. Europe Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2017-2022)

Table 57. Europe Autoimmune Disorder Drug Delivery Device Sales by Application (2017-2022) & (K Units)

Table 58. Europe Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Autoimmune Disorder Drug Delivery Device

Table 68. Key Market Challenges & Risks of Autoimmune Disorder Drug Delivery Device

Table 69. Key Industry Trends of Autoimmune Disorder Drug Delivery Device

Table 70. Autoimmune Disorder Drug Delivery Device Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Autoimmune Disorder Drug Delivery Device Distributors List

Table 73. Autoimmune Disorder Drug Delivery Device Customer List

Table 74. Global Autoimmune Disorder Drug Delivery Device Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Autoimmune Disorder Drug Delivery Device Sales Market Forecast by Region

Table 76. Global Autoimmune Disorder Drug Delivery Device Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Autoimmune Disorder Drug Delivery Device Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Autoimmune Disorder Drug Delivery Device Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Autoimmune Disorder Drug Delivery Device Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Autoimmune Disorder Drug Delivery Device Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Autoimmune Disorder Drug Delivery Device Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Autoimmune Disorder Drug Delivery Device Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Autoimmune Disorder Drug Delivery Device Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Autoimmune Disorder Drug Delivery Device Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Autoimmune Disorder Drug Delivery Device Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Autoimmune Disorder Drug Delivery Device Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Autoimmune Disorder Drug Delivery Device Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Autoimmune Disorder Drug Delivery Device Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share Forecast by Application (2023-2028)

Table 94. AbbVie Inc. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors

Table 95. AbbVie Inc. Autoimmune Disorder Drug Delivery Device Product Offered

Table 96. AbbVie Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. AbbVie Inc. Main Business

Table 98. AbbVie Inc. Latest Developments

Table 99. Amgen Inc. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors

Table 100. Amgen Inc. Autoimmune Disorder Drug Delivery Device Product Offered

Table 101. Amgen Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Amgen Inc. Main Business

Table 103. Amgen Inc. Latest Developments

Table 104. F. Hoffmann- La Roche Ltd. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors

Table 105. F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Product Offered

Table 106. F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. F. Hoffmann- La Roche Ltd. Main Business

Table 108. F. Hoffmann- La Roche Ltd. Latest Developments

Table 109. Novartis AG Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors

Table 110. Novartis AG Autoimmune Disorder Drug Delivery Device Product Offered

Table 111. Novartis AG Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Novartis AG Main Business

Table 113. Novartis AG Latest Developments

Table 114. GlaxoSmithKline Plc Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors

Table 115. GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Product Offered

Table 116. GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. GlaxoSmithKline Plc Main Business

Table 118. GlaxoSmithKline Plc Latest Developments

Table 119. Biogen Inc. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors

Table 120. Biogen Inc. Autoimmune Disorder Drug Delivery Device Product Offered

Table 121. Biogen Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Biogen Inc. Main Business

Table 123. Biogen Inc. Latest Developments

Table 124. Merck KGaA Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors

Table 125. Merck KGaA Autoimmune Disorder Drug Delivery Device Product Offered

Table 126. Merck KGaA Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. Merck KGaA Main Business

Table 128. Merck KGaA Latest Developments

Table 129. Bayer AG Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors

Table 130. Bayer AG Autoimmune Disorder Drug Delivery Device Product Offered

Table 131. Bayer AG Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. Bayer AG Main Business

Table 133. Bayer AG Latest Developments

Table 134. Johnson & Johnson Services Inc. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors

Table 135. Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Product Offered

Table 136. Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. Johnson & Johnson Services Inc. Main Business

Table 138. Johnson & Johnson Services Inc. Latest Developments

Table 139. Teva Pharmaceutical Industries Ltd. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors

Table 140. Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Product Offered

Table 141. Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Teva Pharmaceutical Industries Ltd. Main Business

Table 143. Teva Pharmaceutical Industries Ltd. Latest Developments

Table 144. Eli Lily and Company Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors

Table 145. Eli Lily and Company Autoimmune Disorder Drug Delivery Device Product Offered

Table 146. Eli Lily and Company Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. Eli Lily and Company Main Business

Table 148. Eli Lily and Company Latest Developments

Table 149. Sanofi S.A. Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors

Table 150. Sanofi S.A. Autoimmune Disorder Drug Delivery Device Product Offered

Table 151. Sanofi S.A. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. Sanofi S.A. Main Business

Table 153. Sanofi S.A. Latest Developments

Table 154. Takeda Pharmaceutical Company Limited Basic Information, Autoimmune Disorder Drug Delivery Device Manufacturing Base, Sales Area and Its Competitors

Table 155. Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Product Offered

Table 156. Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. Takeda Pharmaceutical Company Limited Main Business

Table 158. Takeda Pharmaceutical Company Limited Latest Developments

List of Figures

Figure 1. Picture of Autoimmune Disorder Drug Delivery Device

Figure 2. Autoimmune Disorder Drug Delivery Device Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Autoimmune Disorder Drug Delivery Device Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Autoimmune Disorder Drug Delivery Device Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Autoimmune Disorder Drug Delivery Device Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Pen Injectors

Figure 10. Product Picture of Auto-Injectors

Figure 11. Product Picture of Prefilled Syringes

Figure 12. Product Picture of Vials

Figure 13. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type in 2021

Figure 14. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Type (2017-2022)

Figure 15. Autoimmune Disorder Drug Delivery Device Consumed in In-house Manufacturing

Figure 16. Global Autoimmune Disorder Drug Delivery Device Market: In-house Manufacturing (2017-2022) & (K Units)

Figure 17. Autoimmune Disorder Drug Delivery Device Consumed in Outsourced Manufacturing

Figure 18. Global Autoimmune Disorder Drug Delivery Device Market: Outsourced Manufacturing (2017-2022) & (K Units)

Figure 19. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2017-2022)

Figure 20. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Application in 2021

Figure 21. Autoimmune Disorder Drug Delivery Device Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Company in 2021

Figure 23. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Geographic Region in 2021

Figure 25. Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Region (2017-2022)

Figure 26. Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country/Region in 2021

Figure 27. Americas Autoimmune Disorder Drug Delivery Device Sales 2017-2022 (K Units)

Figure 28. Americas Autoimmune Disorder Drug Delivery Device Revenue 2017-2022 ($ Millions)

Figure 29. APAC Autoimmune Disorder Drug Delivery Device Sales 2017-2022 (K Units)

Figure 30. APAC Autoimmune Disorder Drug Delivery Device Revenue 2017-2022 ($ Millions)

Figure 31. Europe Autoimmune Disorder Drug Delivery Device Sales 2017-2022 (K Units)

Figure 32. Europe Autoimmune Disorder Drug Delivery Device Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue 2017-2022 ($ Millions)

Figure 35. Americas Autoimmune Disorder Drug Delivery Device Sales Market Share by Country in 2021

Figure 36. Americas Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country in 2021

Figure 37. United States Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Autoimmune Disorder Drug Delivery Device Sales Market Share by Region in 2021

Figure 42. APAC Autoimmune Disorder Drug Delivery Device Revenue Market Share by Regions in 2021

Figure 43. China Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Autoimmune Disorder Drug Delivery Device Sales Market Share by Country in 2021

Figure 50. Europe Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country in 2021

Figure 51. Germany Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue Market Share by Country in 2021

Figure 58. Egypt Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Autoimmune Disorder Drug Delivery Device Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Autoimmune Disorder Drug Delivery Device in 2021

Figure 64. Manufacturing Process Analysis of Autoimmune Disorder Drug Delivery Device

Figure 65. Industry Chain Structure of Autoimmune Disorder Drug Delivery Device

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles